Human anti‐ErbB2 immunoagents–immunoRNases and compact antibodies
C De Lorenzo, G D'Alessio - The FEBS Journal, 2009 - Wiley Online Library
Immunotherapy, based on mAbs specifically directed against cancer cells, is considered a
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
Human anti-ErbB2 immunoagents–immunoRNases and compact antibodies.
C De Lorenzo, G D'Alessio - FEBS Journal, 2009 - search.ebscohost.com
Immunotherapy, based on mAbs specifically directed against cancer cells, is considered a
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies
C De Lorenzo, G D'Alessio - The FEBS journal, 2009 - pubmed.ncbi.nlm.nih.gov
Immunotherapy, based on mAbs specifically directed against cancer cells, is considered a
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies
C De Lorenzo, G D'Alessio - FEBS Journal, 2009 - hero.epa.gov
Immunotherapy, based on mAbs specifically directed against cancer cells, is considered a
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
Human anti-ErbB2 immunoagents--immunoRNases and compact antibodies.
C De Lorenzo, G D'Alessio - The FEBS Journal, 2008 - europepmc.org
Immunotherapy, based on mAbs specifically directed against cancer cells, is considered a
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
Human anti-ErbB2 immunoagents–immunoRNases and compact antibodies
C DE LORENZO, G D'Alessio - THE FEBS JOURNAL, 2009 - iris.unina.it
Immunotherapy, based on mAbs specifically directed against cancer cells, is considered a
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …
precious strategy in the fight against cancer because of its selectivity and lack of multidrug …